市場調査レポート
商品コード
1583848

インスリンの世界市場 2024年~2028年

Global Insulin Market 2024-2028


出版日
発行
TechNavio
ページ情報
英文 161 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
インスリンの世界市場 2024年~2028年
出版日: 2024年08月23日
発行: TechNavio
ページ情報: 英文 161 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インスリン市場は、2023年から2028年にかけて12億9,930万米ドル、予測期間中のCAGRは1.38%で成長すると予測されています。

当レポートでは、インスリン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、糖尿病有病率の増加、糖尿病につながる危険因子への曝露の増加、および有利な政府の取り組みによって牽引されています。

市場範囲
基準年 2024
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 1.35%
CAGR 1.38%
増分額 12億9,930万米ドル

本調査では、今後数年間のインスリン市場成長を牽引する主な要因の一つとして、インスリンデリバリーシステムの進歩を挙げています。また、在宅療養環境への注目の高まり、糖尿病に対する意識の高まり、イニシアチブの拡大は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第3章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023年
  • 市場の見通し 2023年~2028年

第4章 市場規模実績

  • インスリンの世界市場 2018年~2022年
  • タイプ別セグメント分析 2018年~2022年
  • 流通チャネル別セグメント分析 2018年~2022年
  • 地域別セグメント分析 2018年~2022年
  • 国別セグメント分析 2018年~2022年

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 タイプ別市場セグメンテーション

  • 市場セグメンテーション
  • 比較:タイプ別
  • インスリンアナログ:市場規模と予測 2023年~2028年
  • 人間インスリン:市場規模と予測 2023年~2028年
  • タイプ別の市場機会

第7章 流通チャネル別市場セグメンテーション

  • 市場セグメンテーション
  • 比較:流通チャネル別
  • 小売薬局:市場規模と予測 2023年~2028年
  • 病院:市場規模と予測 2023年~2028年
  • オンライン薬局:市場規模と予測 2023年~2028年
  • 流通チャネル別の市場機会

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023年~2028年
  • 欧州:市場規模と予測 2023年~2028年
  • アジア:市場規模と予測 2023年~2028年
  • 世界のその他の地域:市場規模と予測 2023年~2028年
  • 米国:市場規模と予測 2023年~2028年
  • 英国:市場規模と予測 2023年~2028年
  • ドイツ:市場規模と予測 2023年~2028年
  • 中国:市場規模と予測 2023年~2028年
  • 日本:市場規模と予測 2023年~2028年
  • 地域情勢別市場機会

第10章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第11章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第12章 競合分析

  • 企業プロファイル
  • 企業の市場ポジショニング
  • B.Braun SE
  • Becton Dickinson and Co.
  • Biocon Ltd.
  • Cardinal Health Inc.
  • CODAN Medizinische Gerate GmbH and Co KG
  • Eli Lilly and Co.
  • Gerresheimer AG
  • Gulf Pharmaceutical Industries
  • Hindustan Syringes and Medical Devices Ltd.
  • Mayo Foundation for Medical Education and Research
  • Nipro Corp.
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi SA
  • Wockhardt Ltd.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global Insulin Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on Type - Market share 2023-2028 (%)
  • Exhibits33: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by Type
  • Exhibits35: Data Table on Comparison by Type
  • Exhibits36: Chart on Insulin analog - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Insulin analog - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Insulin analog - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Insulin analog - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Human insulin - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Human insulin - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Human insulin - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Human insulin - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Market opportunity by Type ($ million)
  • Exhibits45: Data Table on Market opportunity by Type ($ million)
  • Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits48: Chart on Comparison by Distribution Channel
  • Exhibits49: Data Table on Comparison by Distribution Channel
  • Exhibits50: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
  • Exhibits51: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
  • Exhibits52: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
  • Exhibits53: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
  • Exhibits54: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits55: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits56: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits57: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits58: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
  • Exhibits59: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
  • Exhibits60: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
  • Exhibits61: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
  • Exhibits62: Market opportunity by Distribution Channel ($ million)
  • Exhibits63: Data Table on Market opportunity by Distribution Channel ($ million)
  • Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits67: Chart on Geographic comparison
  • Exhibits68: Data Table on Geographic comparison
  • Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Market opportunity By Geographical Landscape ($ million)
  • Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits107: Impact of drivers and challenges in 2023 and 2028
  • Exhibits108: Overview on criticality of inputs and factors of differentiation
  • Exhibits109: Overview on factors of disruption
  • Exhibits110: Impact of key risks on business
  • Exhibits111: Companies covered
  • Exhibits112: Matrix on companies position and classification
  • Exhibits113: B.Braun SE - Overview
  • Exhibits114: B.Braun SE - Business segments
  • Exhibits115: B.Braun SE - Key news
  • Exhibits116: B.Braun SE - Key offerings
  • Exhibits117: B.Braun SE - Segment focus
  • Exhibits118: Becton Dickinson and Co. - Overview
  • Exhibits119: Becton Dickinson and Co. - Business segments
  • Exhibits120: Becton Dickinson and Co. - Key news
  • Exhibits121: Becton Dickinson and Co. - Key offerings
  • Exhibits122: Becton Dickinson and Co. - Segment focus
  • Exhibits123: Biocon Ltd. - Overview
  • Exhibits124: Biocon Ltd. - Business segments
  • Exhibits125: Biocon Ltd. - Key offerings
  • Exhibits126: Biocon Ltd. - Segment focus
  • Exhibits127: Cardinal Health Inc. - Overview
  • Exhibits128: Cardinal Health Inc. - Business segments
  • Exhibits129: Cardinal Health Inc. - Key news
  • Exhibits130: Cardinal Health Inc. - Key offerings
  • Exhibits131: Cardinal Health Inc. - Segment focus
  • Exhibits132: CODAN Medizinische Gerate GmbH and Co KG - Overview
  • Exhibits133: CODAN Medizinische Gerate GmbH and Co KG - Product / Service
  • Exhibits134: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
  • Exhibits135: Eli Lilly and Co. - Overview
  • Exhibits136: Eli Lilly and Co. - Product / Service
  • Exhibits137: Eli Lilly and Co. - Key news
  • Exhibits138: Eli Lilly and Co. - Key offerings
  • Exhibits139: Gerresheimer AG - Overview
  • Exhibits140: Gerresheimer AG - Business segments
  • Exhibits141: Gerresheimer AG - Key news
  • Exhibits142: Gerresheimer AG - Key offerings
  • Exhibits143: Gerresheimer AG - Segment focus
  • Exhibits144: Gulf Pharmaceutical Industries - Overview
  • Exhibits145: Gulf Pharmaceutical Industries - Product / Service
  • Exhibits146: Gulf Pharmaceutical Industries - Key offerings
  • Exhibits147: Hindustan Syringes and Medical Devices Ltd. - Overview
  • Exhibits148: Hindustan Syringes and Medical Devices Ltd. - Product / Service
  • Exhibits149: Hindustan Syringes and Medical Devices Ltd. - Key offerings
  • Exhibits150: Mayo Foundation for Medical Education and Research - Overview
  • Exhibits151: Mayo Foundation for Medical Education and Research - Product / Service
  • Exhibits152: Mayo Foundation for Medical Education and Research - Key offerings
  • Exhibits153: Nipro Corp. - Overview
  • Exhibits154: Nipro Corp. - Business segments
  • Exhibits155: Nipro Corp. - Key offerings
  • Exhibits156: Nipro Corp. - Segment focus
  • Exhibits157: Novo Nordisk AS - Overview
  • Exhibits158: Novo Nordisk AS - Business segments
  • Exhibits159: Novo Nordisk AS - Key news
  • Exhibits160: Novo Nordisk AS - Key offerings
  • Exhibits161: Novo Nordisk AS - Segment focus
  • Exhibits162: Pfizer Inc. - Overview
  • Exhibits163: Pfizer Inc. - Product / Service
  • Exhibits164: Pfizer Inc. - Key news
  • Exhibits165: Pfizer Inc. - Key offerings
  • Exhibits166: Sanofi SA - Overview
  • Exhibits167: Sanofi SA - Business segments
  • Exhibits168: Sanofi SA - Key news
  • Exhibits169: Sanofi SA - Key offerings
  • Exhibits170: Sanofi SA - Segment focus
  • Exhibits171: Wockhardt Ltd. - Overview
  • Exhibits172: Wockhardt Ltd. - Business segments
  • Exhibits173: Wockhardt Ltd. - Key offerings
  • Exhibits174: Wockhardt Ltd. - Segment focus
  • Exhibits175: Inclusions checklist
  • Exhibits176: Exclusions checklist
  • Exhibits177: Currency conversion rates for US$
  • Exhibits178: Research methodology
  • Exhibits179: Information sources
  • Exhibits180: Data validation
  • Exhibits181: Validation techniques employed for market sizing
  • Exhibits182: Data synthesis
  • Exhibits183: 360 degree market analysis
  • Exhibits184: List of abbreviations
目次
Product Code: IRTNTR74807

The insulin market is forecasted to grow by USD 1299.3 mn during 2023-2028, accelerating at a CAGR of 1.38% during the forecast period. The report on the insulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of diabetes, increasing exposure to risk factors that lead to diabetes, and favorable government initiatives.

Technavio's insulin market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20241.35%
CAGR1.38%
Incremental Value$1299.3 mn

By Type

    • Insulin analog
    • Human insulin

By Distribution Channel

    • Retail pharmacies
    • Hospitals
    • Online pharmacies

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the advances in insulin delivery systems as one of the prime reasons driving the insulin market growth during the next few years. Also, increasing focus on home care settings and increase in awareness of diabetes and growing initiatives will lead to sizable demand in the market.

The report on the insulin market covers the following areas:

    • Insulin market sizing
    • Insulin market forecast
    • Insulin market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insulin market vendors that include AdvaCare Pharma, ASP Healthcare Pty Ltd., B.Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hi Tech Medics Pvt Ltd., Hindustan Syringes and Medical Devices Ltd., Mayo Foundation for Medical Education and Research, Nipro Corp., Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., and Wockhardt Ltd.. Also, the insulin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Distribution Channel
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Insulin Market 2018 - 2022
    • Historic Market Size - Data Table on Global Insulin Market 2018 - 2022 ($ million)
  • 4.2 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.3 Distribution Channel segment analysis 2018 - 2022
    • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

  • 6.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 6.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 6.3 Insulin analog - Market size and forecast 2023-2028
    • Chart on Insulin analog - Market size and forecast 2023-2028 ($ million)
    • Data Table on Insulin analog - Market size and forecast 2023-2028 ($ million)
    • Chart on Insulin analog - Year-over-year growth 2023-2028 (%)
    • Data Table on Insulin analog - Year-over-year growth 2023-2028 (%)
  • 6.4 Human insulin - Market size and forecast 2023-2028
    • Chart on Human insulin - Market size and forecast 2023-2028 ($ million)
    • Data Table on Human insulin - Market size and forecast 2023-2028 ($ million)
    • Chart on Human insulin - Year-over-year growth 2023-2028 (%)
    • Data Table on Human insulin - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

  • 7.1 Market segments
    • Chart on Distribution Channel - Market share 2023-2028 (%)
    • Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 7.2 Comparison by Distribution Channel
    • Chart on Comparison by Distribution Channel
    • Data Table on Comparison by Distribution Channel
  • 7.3 Retail pharmacies - Market size and forecast 2023-2028
    • Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
    • Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
    • Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
    • Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
  • 7.4 Hospitals - Market size and forecast 2023-2028
    • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • 7.5 Online pharmacies - Market size and forecast 2023-2028
    • Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
    • Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
    • Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
    • Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by Distribution Channel
    • Market opportunity by Distribution Channel ($ million)
    • Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.9 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 B.Braun SE
    • B.Braun SE - Overview
    • B.Braun SE - Business segments
    • B.Braun SE - Key news
    • B.Braun SE - Key offerings
    • B.Braun SE - Segment focus
  • 12.4 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
  • 12.5 Biocon Ltd.
    • Biocon Ltd. - Overview
    • Biocon Ltd. - Business segments
    • Biocon Ltd. - Key offerings
    • Biocon Ltd. - Segment focus
  • 12.6 Cardinal Health Inc.
    • Cardinal Health Inc. - Overview
    • Cardinal Health Inc. - Business segments
    • Cardinal Health Inc. - Key news
    • Cardinal Health Inc. - Key offerings
    • Cardinal Health Inc. - Segment focus
  • 12.7 CODAN Medizinische Gerate GmbH and Co KG
    • CODAN Medizinische Gerate GmbH and Co KG - Overview
    • CODAN Medizinische Gerate GmbH and Co KG - Product / Service
    • CODAN Medizinische Gerate GmbH and Co KG - Key offerings
  • 12.8 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key news
    • Eli Lilly and Co. - Key offerings
  • 12.9 Gerresheimer AG
    • Gerresheimer AG - Overview
    • Gerresheimer AG - Business segments
    • Gerresheimer AG - Key news
    • Gerresheimer AG - Key offerings
    • Gerresheimer AG - Segment focus
  • 12.10 Gulf Pharmaceutical Industries
    • Gulf Pharmaceutical Industries - Overview
    • Gulf Pharmaceutical Industries - Product / Service
    • Gulf Pharmaceutical Industries - Key offerings
  • 12.11 Hindustan Syringes and Medical Devices Ltd.
    • Hindustan Syringes and Medical Devices Ltd. - Overview
    • Hindustan Syringes and Medical Devices Ltd. - Product / Service
    • Hindustan Syringes and Medical Devices Ltd. - Key offerings
  • 12.12 Mayo Foundation for Medical Education and Research
    • Mayo Foundation for Medical Education and Research - Overview
    • Mayo Foundation for Medical Education and Research - Product / Service
    • Mayo Foundation for Medical Education and Research - Key offerings
  • 12.13 Nipro Corp.
    • Nipro Corp. - Overview
    • Nipro Corp. - Business segments
    • Nipro Corp. - Key offerings
    • Nipro Corp. - Segment focus
  • 12.14 Novo Nordisk AS
    • Novo Nordisk AS - Overview
    • Novo Nordisk AS - Business segments
    • Novo Nordisk AS - Key news
    • Novo Nordisk AS - Key offerings
    • Novo Nordisk AS - Segment focus
  • 12.15 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 12.16 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
  • 12.17 Wockhardt Ltd.
    • Wockhardt Ltd. - Overview
    • Wockhardt Ltd. - Business segments
    • Wockhardt Ltd. - Key offerings
    • Wockhardt Ltd. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations